Eos Energy stock falls after Fuzzy Panda issues short report
LONDON - Abingdon Health plc (AIM:ABDX), a developer and manufacturer of rapid diagnostic tests, announced Tuesday it has launched a retail offer to raise up to £200,000 through the issuance of new ordinary shares.
The retail offer, conducted via BookBuild platform, is priced at 6 pence per share, representing a 0.8% discount to the closing price of 6.05 pence on October 10, 2025.
The retail offer follows a separate placing of new ordinary shares at the same price, which was announced on October 13. The company stated that completion of the retail offer is conditional upon the placing proceeding, admission of shares, and shareholder approval of resolutions at a General Meeting scheduled for October 30.
Abingdon Health indicated the retail offer is being made available to eligible retail shareholders in the United Kingdom through financial intermediaries listed on the BookBuild website. The offer opened at 8:30 a.m. on October 14 and is expected to close at 4:30 p.m. on October 16, though it may close earlier if oversubscribed.
Zeus Capital Limited is acting as retail offer coordinator for the transaction.
The company noted that admission of the retail offer shares is expected to take place on October 31, 2025, pending satisfaction of all conditions.
According to the press release statement, Abingdon Health values its retail shareholder base and believes it appropriate to provide eligible retail shareholders the opportunity to participate alongside institutional investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.